Secukinumab: A life-changing treatment for Netherton syndrome?

Affiliations

¹ Department of Dermatology, Hôtel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon. Electronic address: Jerome.kaikati@net.usj.edu.lb.
² Department of Dermatology, Hôtel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

Jerome Kaikati et al. Ann Dermatol Venereol. 2023 Mar.

. 2023 Mar;150(1):61-63.

doi: 10.1016/j.annder.2022.08.005. Epub 2022 Nov 22.

¹ Department of Dermatology, Hôtel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon. Electronic address: Jerome.kaikati@net.usj.edu.lb.
² Department of Dermatology, Hôtel Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.

No abstract available

Keywords: IL-17 inhibitor; Netherton syndrome; Secukinumab.

Publication types